US Oncologist Survey: Optimizing Treatment for Advanced Prostate Cancer Analysis

Patient case scenarios that progressively unfold, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of patients. 

View Full Report with TOC at: http://www.researchmoz.us/us-oncologist-survey-optimizing-treatment-for-advanced-prostate-cancer-report.html

Patient case scenarios that progressively unfold, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of patients. This primary research provides the oncology prescribing information that you are missing, directly from high-prescribing US Oncologists on the treatment of patients with advanced prostate cancer.

Table of Contents

Chapter 1: IntroductionTable 1. Treatment Options in Advanced Prostate Cancer

Chapter 2: Respondent DemographicsTable 2.1 Eligibility Criteria for Survey ParticipationFigure 2.1 Gender of Survey RespondentsFigure 2.2 Years Since Medical School GraduationFigure 2.3 Practice SettingsFigure 2.4 Practices in NCI Cancer CentersFigure 2.5 Geographic SettingsFigure 2.6 Survey Respondents by StatesFigure 2.7 Number of Physicians in Practice GroupsFigure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen

Chapter 3: Treatment of a patient with increased PSA and adenocarcinomaNext step in a patient with increased PSA and adenocarcinomaFigure 3.1Tests to be performed at this time with the patientFigure 3.2Confidence in treating to optimal outcomeFigure 3.3Treatment decision with disease progressionFigure 3.4Treatment decision with disease progressionFigure 3.5Factors that influenced treatmentFigure 3.6

Chapter 4: Elderly patient treated for Gleason’s 7 adenocarcinoma, increased PSA 18 months later 23Barriers to optimal treatmentFigure 4.1Confidence in treating to optimal outcomeFigure 4.2Treatment following rising PSA on leuprolideFigure 4.3Treatment decision upon disease progressionFigure 4.4Factors that influenced treatmentFigure 4.5Factors that influenced treatment by chosen agentTable 4.1Other agents that would be appropriate to include in therapyFigure 4.6Treatment upon rising PSAFigure 4.6Treatment upon further disease progressionFigure 4.7

Browse More related reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About Us:

ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact:

Email: sales@researchmoz.us

Website @ http://www.researchmoz.us/To 

Get Popular Reports Visit Blog : http://www.marketnresearch.com/Get 

More Market Research Report : https://www.linkedin.com/today/author/227772465